Loading...
Loading...
Analysts at UBS initiated coverage on shares of Concert Pharmaceuticals
CNCE with a “buy” rating. The target price for Concert Pharma is set to $25. Concert Pharma's shares closed at $14.88 on Friday.
HC Wainwright initiated coverage on shares of BioCryst Pharmaceuticals
BCRX with a “buy” rating. The target price for BioCryst Pharmaceuticals is set to $21. BioCryst's shares closed at $11.46 on Friday.
Analysts at Cantor Fitzgerald initiated coverage on shares of Eagle Pharmaceuticals
EGRX with a “buy” rating. The target price for Eagle Pharma is set to $21. Eagle Pharma's shares closed at $14.92 on Friday.
Deutsche Bank initiated coverage on shares of Installed Building Products
IBP with a “buy” rating. The target price for Installed Building Products is set to $18. Installed Building's shares closed at $14.78 on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in